Teva to Pay $85 Million Settlement in Oklahoma Opioid Case | Time
The Unlikely Source of a Healthtech Revolution - Bloomberg
Analysis: Teva Pharmaceuticals is bogged down by legal issues, fails to kick-start growth | Ctech
Teva shares jump in Tel Aviv after report of up to 10,000 job cuts | The Times of Israel
Opioid crisis: 4 pharmaceutical companies accused in the opioid epidemic reach a $260 million settlement just before trial | CNN
Teva Wins Appeal That Upholds Three Patents for Migraine Drug
Pfizer gets $2.15 billion settlement
Teva Pharma's Short Sellers Double Down as Legal Woes Drag On
New York jury holds drug firm Teva liable in opioid crisis
Israeli Drugmaker Teva in Talks to Help Produce Covid-19 Vaccines
Teva Pharmaeutical Stock Gets Upgrade From Analyst | Barron's
Glaxo's Win in Case Against Teva Lifts Other Drugmakers - BNN Bloomberg
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Teva Gets Generic Drugmakers' Backing in Bid to Redo Label Case
Teva Pharmaceutical Industries is in talks to manufacture and distribute COVID vaccines | Fortune
US states accuse Teva and other drugmakers of colluding to inflate prices over 1,000%
Teva CEO Kare Schultz Says Drugmaker Will Fight US Price-Fixing Charges - Bloomberg
Teva Wins Ruling Tossing $235 Million Glaxo Drug Verdict - Bloomberg
Teva Negotiating Sale of Remaining Women's Health Assets, Report Says | Ctech
Generic Makers to Challenge Ruling Upholding Teva Cancer Drug
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York state - ABC17NEWS
Teva Loses CEO, Leaving Investors to Guess What's Next - Bloomberg
Teva Abandons Search to Make Covid-19 Vaccine for Partners - Bloomberg
Teva CEO Rejects Netanyahu Plea to Salvage Jerusalem Plant - Bloomberg
The Difficulties of Cloning a CEO - Bloomberg
